Arthroscopic Rotator Cuff Repair Clinical Trial
Official title:
Augmentation of Rotator Cuff Repair With Biodegradable Magnesium Pin: From Bench Side to Bedside
Rotator cuff tears are one of the most common conditions encountered in orthopaedic practice leading to significant shoulder pain and functional deficit. The incidence of rotator cuff tears increases with age and previous trauma. Arthroscopic rotator cuff repair (ARCR) is a surgical procedure to reattach the torn edge of the tendon to the underlying bone, which can improve the clinical symptoms of patients. However, the retear rate after arthroscopic repair is as high as 94% (1). The high re-tear rate following cuff repair is due to the lack of a strong tendon to bone integration. The natural healing responses after surgical reattachment are too weak to regenerate strong tendon insertion, primarily owing to insufficient osteogenesis. To enhance the bone-tendon interface (BTI) healing, the investigators have developed a magnesium pin that can be applied to the cuff repair site to improve the BTI healing.This study is a single-center, randomized controlled trial to investigate the effect of using magnesium pin as a suture to augment rotator cuff repair. The intervention groups receives treated using magnesium pin additional to the suture anchor used routinely in clinical practice, whereas the control group receives routine suture anchor for the treatment-as-usual (TAU). The investigators hypothesize the magnesium pin applied in arthroscopic rotator cuff tears can promote BTI healing and reduce the cumulative retear rate with better functional outcomes.
Status | Not yet recruiting |
Enrollment | 40 |
Est. completion date | December 2026 |
Est. primary completion date | May 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years and older |
Eligibility | Inclusion Criteria: - Subject requires Arthroscopic rotator cuff repair (ARCR) and amenable to repair. - Subject is > 40 years of age (no upper limit); - Subject provides written informed consent for study participation using an Independent Ethical Committee (IEC) / Institutional Review Board (IRB) approved consent form; - Subject is willing and able to participate in required follow-up visits and is able to complete study activities. Exclusion Criteria: - Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications; - Subjects with Samilson-Prieto osteoarthritis > 2; - Subjects with current or prior infection of the ipsilateral shoulder; - Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, or chronic joint disease; - Subjects with prior shoulder surgery (not including rotator cuff repair (revision repair subject group only), biceps tenodesis/tenotomy, distal clavicle excision (DCE), ubacromial decompression); - Subjects with an irreparable or partially reparable rotator cuff tear; - Subjects with a subscapularis tear requiring repair; - Subjects requiring a concomitant labral fixation procedure; - Subjects requiring a concomitant os acromiale fixation procedure - Subjects with glenohumeral joint instability (multiple dislocations/subluxations); - Subjects with a subacromial or intra-articular injection within 3 months prior to surgery; - Subjects with condition(s) that contraindicate or complicate outcomes of ARCR e.g., > Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy > Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head or glenoid, history of immunodeficiency disorders, history of chronic inflammatory disorders, oral or injected steroid use in last 4 weeks; - Pregnancy or possibility of pregnancy - Patient's inability to understand written and spoken Chinese, Mandarin or English. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | The Chinese University of Hong Kong | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Imaging Examinations | Upper extremity Magnetic resonance imaging (MRI) for study participants will be collected at Baseline, at 3, 6 and 12 months. The Baseline (pre-operative) MRI follows standard of care imaging and will not follow the study MRI Image Acquisition Protocol. The Baseline MRI must occur within 6 months of enrollment into this study. MRI at 3, 6- and 12-months post-surgery will be collected per Image Acquisition Protocol. Total tendon thickness (mm), tendon length (mm), size of retear (anteroposterior /mediolateral), and shape of retear will be recorded. | Baseline, post-operative 3 months, 6 months, and 12 months. | |
Primary | Cofield classification | The Cofield classification system will be used for all MRI analyses to assess the size of full-thickness tears(FTT) :
• Small = < 1 cm • Medium = 1-3 cm • Large = 3-5 cm • Massive = > 5 cm |
Baseline, post-operative 3 months, 6 months, and 12 months. | |
Primary | Sugaya Score | The Sugaya score will be used to determine postoperative cuff integrity through magnetic resonance imaging classified into 5 categories: Type I to Type V. Type I indicates sufficient thickness with homogenously low intensity. Type II indicates sufficient thickness with partial high intensity. Type III indicates insufficient thickness without discontinuity. Type IV indicates presence of a minor discontinuity, suggesting a small full-thickness tear. Type V indicates the presence of a major discontinuity, suggesting a medium or large full-thickness tear. | Baseline, post-operative 3 months, 6 months, and 12 months. | |
Primary | Goutallier Classification | The Goutallier classification will be used to classify the fatty infiltration of the rotator cuff. The Goutallier classification ranges from a grade of 0 indicating a completely normal muscles without any fatty streaks to a grade of 4 which indicates that more fat than muscle is present . Grade 0: Completely normal muscle, without any fatty streaks, Grade 1: Some fatty streaks, Grade 2: Increased fatty infiltration, but more muscle than fat, Grade 3: Equal amounts of fat and muscle, Grade 4: more fat than muscle. | Baseline, post-operative 3 months, 6 months, and 12 months. | |
Secondary | Height measurement | Height will be measured and report in meter. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Weight measurement | Weight will be measured and report in kg. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | BMI measurement | Weight and height will be measured and combined to report Body mass index (BMI) in kg/m^2. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Shoulder flexibility (range of motion) | The passive range of shoulder flexion, shoulder abduction and shoulder internal and external rotation will be measured by a goniometer with the participant lying supine. Three measurements will be recorded and averaged for analysis. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Shoulder muscle strength | The isometric force of shoulder internal and external rotation will be measured using a handheld dynamometer (HOGGAN Health Industries Inc, West Jordan, Utah). The subject will be asked to push against the examiner's resistance for 5 seconds. Three measurements will be recorded and averaged for analysis. The peak force will be normalized with the participant's body weight. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Western Ontario Rotator Cuff (WORC) Index Western Ontario Rotator Cuff (WORC) Index Index | The WORC Index is a 21-item questionnaire assessing quality of life, evaluating the change in symptoms and functional ability, specific to rotator cuff tendinopathy; it is often used to compare pre-and postoperative changes in patients with a clinical diagnosis of an impingement syndrome, rotator cuff tendinopathy as well as arthroscopic rotator cuff repairs (ARCR).Raw scores range from 0 to 2100, with a higher score indicating decreased quality of life because of pathological condition of the rotator cuff. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Constant-Murley Score | The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The test is divided into four subscales: pain, activities of daily living, strength and range of motion (forward elevation, external rotation, abduction and internal rotation of the shoulder. The subjective findings (severity of pain, activities of daily living and working in different positions) comprise 35 points and the objective (examiner-assessed) measurements (arm range of motion without pain, measurements of exo- and endorotation via reference points and measuring muscle strength) comprise the remaining 65 points, for a total of 100 points. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Visual Analogue Scale (VAS) | Pain is assessed on a 100-point scale ranging from 0 to 100, with zero (0) representing no pain and 100 representing the worst pain imaginable. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | Adverse events | Any events related to the surgery will be recorded. | baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months. | |
Secondary | C-reactive protein measurement | 5 ml blood samples will be collected and analysied for C-reactive protein measurement using a commercially available an enzyme-linked immunosorbent assay (ELISA) kit. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Calcium (Ca) measurement | The measurements of calcium (Ca) will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Magnesium (Mg) measurement | The measurements of Mg will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Phosphorous (P) measurement | The measurements of phosphorous will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Creatinine (Cr) measurement | The measurements of Cr will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Urea measurement | The measurements of urea will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Alanine transaminase (ALT) measurement | The measurements of ALT will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Aspartate aminotransferase (AST) measurement | The measurements of AST will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Total protein (TP) measurement | The measurements of TP will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Albumin (ALB) measurement | The measurements of ALB will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively | |
Secondary | Globulin (GLB) measurement | The measurements of GLB will be taken to monitor potential effect of magnesium pin. | baseline, day 1 post-operatively, 2 weeks, 3 months and 6 months post-operatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04398589 -
The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block
|
Phase 4 | |
Recruiting |
NCT04483063 -
Can Additional Preoperative Skin Cleaning on Face, Neck and Chest With Chlorhexidine Reduce Cutibacterium Acnes Contamination on Sutures in Arthroscopy Rotator Cuff Repair?
|
N/A | |
Recruiting |
NCT05691101 -
Comparison of Using CIBPB With or Without IV-PCA After Arthroscopic Rotator Cuff Repair
|
N/A | |
Completed |
NCT05176028 -
Acute Effects of Fascial Release Technique in Patients With Rotator Cuff Repair
|
N/A | |
Enrolling by invitation |
NCT04636242 -
Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis
|
Phase 3 | |
Recruiting |
NCT05948995 -
Comparison Between Abduction External Rotation Brace and Arm Sling After Arthroscopic Rotator Cuff
|
N/A |